Results 41 to 50 of about 1,453,502 (192)

Meshalkin National Medical Research Center

open access: yesРоссийский кардиологический журнал, 2021
We present three cases of successful transatrial transcatheter valve-in-valve implantation in patients with bioprosthetic mitral valve dysfunction.
A. V. Bogachev-Prokofiev   +10 more
doaj   +1 more source

Transcatheter Aortic Valve Implantation: Long-Term Outcomes and Durability

open access: yesMethodist DeBakey Cardiovascular Journal, 2023
Transcatheter aortic valve implantation (TAVI) has become the standard of care in symptomatic older patients with severe aortic stenosis regardless of surgical risk.
Parth V. Desai   +3 more
doaj   +1 more source

Paediatric nanofibrous bioprosthetic heart valve

open access: yesIET Nanobiotechnology, 2017
The search for an optimal aortic valve implant with durability, calcification resistance, excellent haemodynamic parameters and ability to withstand mechanical loading is yet to be met. Thus, there has been struggled to fabricate bio‐prosthetics heart valve using bioengineering.
Mehrdad, Namdari   +2 more
openaire   +3 more sources

Valve in valve and valve in ring transcatheter aortic valve implantation [PDF]

open access: yesБългарска кардиология, 2022
In recent years the trend towards surgical bioprosthetic valve implantation, especially among young patients, has increased in order to avoid anticoagulant therapy. The patient’s age remains one of the leading risk factors for valve dysfunction.
P. Simeonov   +5 more
doaj   +3 more sources

Degenerative processes in bioprosthetic mitral valves in juvenile pigs

open access: yesJournal of Cardiothoracic Surgery, 2011
Background Glutaraldehyde-treated bioprosthetic heart valves are commonly used for replacement of diseased heart valves. However, calcification and wear limit their durability, and the development of new and improved bioprosthetic valve designs is needed
Pedersen Torben B   +4 more
doaj   +1 more source

Bioprosthetic valve thrombosis in carcinoid heart disease

open access: yesAnnals of Cardiac Anaesthesia, 2019
Tricuspid regurgitation in carcinoid syndrome leads to significant morbidity and mortality that may warrant a tricuspid valve replacement. However, for patients with high serotonin levels and known hypercoagulable risks, the optimum timing for surgery and postoperative anticoagulation approaches remain unclear.
Kimberly Naden Hollander, Brijen L Joshi
openaire   +3 more sources

Materials and manufacturing perspectives in engineering heart valves: a review

open access: yesMaterials Today Bio, 2020
Valvular heart diseases (VHD) are a major health burden, affecting millions of people worldwide. The treatments for such diseases rely on medicine, valve repair, and artificial heart valves including mechanical and bioprosthetic valves.
F. Oveissi   +4 more
doaj   +1 more source

Silk Fibroin for Cardiovascular Medical Devices: Review of Material Properties, Applications, and Clinical Potential

open access: yesAdvanced NanoBiomed Research, EarlyView.
Silk fibroin is an attractive natural biomaterial that can be engineered into diverse cardiovascular constructs, including vascular grafts, cardiac patches, heart valves, and stent coatings. Its tunable biological and mechanical properties have driven substantial preclinical progress; however, widespread clinical translation in cardiovascular ...
Mahsa Haghighattalab   +8 more
wiley   +1 more source

Design and Fabrication of Three-Dimensional Scaffolds for Tissue Engineering of Human Heart Valves [PDF]

open access: yes, 2008
We developed a new fabrication technique for 3-dimensional scaffolds for tissue engineering of human heart valve tissue. A human aortic homograft was scanned with an X-ray computer tomograph.
Schaefermeier, P. K.   +18 more
core   +1 more source

Comparison of mechanical and bioprosthesis valve in over 70-year-old patients with aortic valve replacement: mechanical & bioprosthesis valve

open access: yesVan Tıp Dergisi, 2018
INTRODUCTION: Postoperative early and midterm results of mechanical valve were compared with bioprosthetic valve in patients over 70 years old who underwent aortic valve replacement (AVR) and/or coronary artery bypass graft (CABG).
Safa Gode   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy